Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Sell
4,299
-67
-2% -$7.74K 0.12% 73
2025
Q4
$460K Buy
4,366
+441
+11% +$41.4K 0.11% 77
2025
Q3
$329K Sell
3,925
-56
-1% -$4.61K 0.08% 86
2025
Q2
$315K Buy
3,981
+204
+5% +$16.2K 0.08% 84
2025
Q1
$339K Buy
3,777
+360
+11% +$33.6K 0.1% 75
2024
Q4
$340K Sell
3,417
-53
-2% -$5.46K 0.1% 71
2024
Q3
$394K Buy
3,470
+3
+0.1% +$356 0.11% 61
2024
Q2
$429K Buy
3,467
+22
+0.6% +$2.83K 0.13% 58
2024
Q1
$455K Buy
3,445
+3
+0.1% +$370 0.31% 27
2023
Q4
$375K Sell
3,442
-50
-1% -$5.19K 0.29% 26
2023
Q3
$360K Buy
3,492
+450
+15% +$48.5K 0.32% 26
2023
Q2
$351K Sell
3,042
-320,612
-99% -$36.4M 0.14% 54
2023
Q1
$3K Buy
323,654
+321,512
+15,010% +$34.7M 0.07% 72
2022
Q4
$238K Buy
+2,142
New +$219K 0.25% 28
2022
Q3
Sell
-2,224
Closed -$203K 24
2022
Q2
$203K Buy
+2,224
New +$197K 0.24% 23
2021
Q3
Sell
-1,704
Closed -$133K 157
2021
Q2
$133K Sell
1,704
-82
-5% -$6.1K 0.2% 34
2021
Q1
$131K Buy
+1,786
New +$132K 0.21% 26

Other funds holding MRK

Summit Wealth Group's MRK Position: Q1 2026 in Review

Summit Wealth Group reduced its Merck (MRK) stake by 1.5% in Q1 2026, selling an estimated $7.74K and leaving 4,299 shares worth $517K. The position accounts for 0.12% of the portfolio, ranked #73.

Summit Wealth Group first reported a position in MRK in Q1 2021 and has held it in 17 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Summit Wealth Group held 4,299 shares of Merck worth $517K as of Q1 2026.
  • Summit Wealth Group sold 67 Merck shares in Q1 2026, an estimated $7.74K.
  • Merck made up 0.12% of Summit Wealth Group's portfolio in Q1 2026, its #73 holding.
  • Summit Wealth Group first reported a position in Merck in Q1 2021 and has held it in 17 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Summit Wealth Group's 13F filing for Q1 2026, filed 4 May 2026.